NCT02455505
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Active, not recruiting

Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 21 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Participants must have a domestic partner or spouse, child (minor or adult), sibling (sister or brother), parent or close friend diagnosed with OR has died from an advanced medical illness
Exclusions: 
https://ClinicalTrials.gov/show/NCT02455505